申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP1070705A1
公开(公告)日:2001-01-24
Novel indole derivatives represented by formula (I) or salts thereof, wherein R1 is aryl-substituted lower alkyl in which the aryl may be substituted by at least one member selected among halogen atoms, aryls, heterocyclic groups, aryl-substituted lower alkyls, aryl-substituted lower alkenyls, lower haloalkyls, (lower cycloalkyl)-substituted lower alkyloxys, (lower cycloalkyloxy)-substituted lower alkyls, aryl-substituted lower alkynyls, aryloxy-substituted lower alkyls, aryl-substituted lower alkyloxys, lower alkylthios, lower alkyloxys, and alkenyls; and R2 is a lower alkyl, lower alkenyl, aryl, or heterocyclic group optionally substituted by halogeno, lower alkyl, lower alkenyl, or aryl. These compounds have a hypoglycemic activity and a PDE5 inhibitory activity and are useful as a drug.
低级卤代烷基、(低级环烷基)取代的低级烷氧基、(低级环烷氧基)取代的低级烷基、芳基取代的低级炔基、芳氧基取代的低级烷基、芳基取代的低级烷氧基、低级烷
硫基、低级烷氧基和烯基;R2 是可选被卤素、低级烷基、低级烯基或芳基取代的低级烷基、低级烯基、芳基或杂环基团。这些化合物具有降血糖活性和 PDE5 抑制活性,可用作药物。